penicillanic acid has been researched along with Blood Poisoning in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (15.07) | 18.7374 |
1990's | 3 (4.11) | 18.2507 |
2000's | 12 (16.44) | 29.6817 |
2010's | 39 (53.42) | 24.3611 |
2020's | 8 (10.96) | 2.80 |
Authors | Studies |
---|---|
Al-Jebawi, Y; Karalic, K; Mhanna, MJ; Shekhawat, P | 1 |
Annecke, T; Bach, F; Bauer, M; Bracht, H; Brenner, T; Brinkmann, A; Frey, O; Hagel, S; Hohn, A; Jarczak, D; Kiehntopf, M; Kluge, S; König, C; Lehmann, T; Michels, G; Müller, C; Neugebauer, S; Nierhaus, A; Pletz, MW; Roberts, JA; Weigand, M; Weismann, D; Witzke, D | 1 |
Taito, S; Yoshihiro, S | 1 |
Alrashed, MA; Borgstrom, MC; Kang, N; Perona, SJ; Torabi, MR | 1 |
Hagel, S; Lehmann, T; Pletz, MW | 1 |
Debaveye, Y; Dreesen, E; Gijsen, M; Spriet, I; Wauters, J | 1 |
Babicky, ML; Behrman, SW; Bentrem, DJ; Bertens, KA; Brajcich, BC; Celinski, SA; Chan, CHF; Cohen, ME; D'Angelica, MI; Dillhoff, M; Dixon, MEB; Ellis, RJ; Fernandez-Del Castillo, C; Gholami, S; Gönen, M; House, MG; Karanicolas, PJ; Ko, CY; Lavu, H; Liu, JB; Maithel, SK; McAuliffe, JC; Ott, MJ; Pitt, HA; Reames, BN; Sanford, DE; Sarpel, U; Scaife, CL; Seo, SK; Serrano, PE; Smith, T; Snyder, RA; Talamonti, MS; Thompson, VM; Weber, SM; Yopp, AC; Zabor, EC | 1 |
Colman, R; De Cock, PA; De Paepe, P; Devreese, M; Dhont, E; Hermans, E; Vande Walle, J; Verougstraete, N; Zeitlinger, M | 1 |
García Carretero, R; Lopez-Lomba, M; Rodriguez-Maya, B; Vazquez-Gomez, O | 1 |
Mueller, BA; Shaw, AR | 1 |
Goodlet, KJ; Nailor, MD; Nicolau, DP | 1 |
Deresinski, S; Watkins, RR | 1 |
Cipelli, R; Dangoor, A; Hodgson, M; Lester, JF; Naik, J; Newsom-Davis, T; Patel, A; Shah, R; Summerhayes, M; Talbot, D; Talbot, T | 1 |
Hatti, M; Odenholt, I; Resman, F; Solomonidi, N; Tham, J | 1 |
Colby, J; Fissell, WH; Groszek, JJ; Patel, P; Seegmiller, A; Shotwell, M; Verhoven, SM; Verstraete, A | 1 |
Docobo-Pérez, F; Domínguez-Herrera, J; Egea, P; López-Cerero, L; López-Rojas, R; Pachón, J; Pascual, A; Rodríguez-Baño, J | 1 |
Falagas, ME; Ikawa, K; Tansarli, GS; Vardakas, KZ | 1 |
Gupta, N; Rodrigues, C; Shetty, A; Soman, R | 1 |
Boots, RJ; Jarrett, P; Kirkpatrick, CM; Lipman, J; Roberts, JA; Varghese, JM | 1 |
Doi, Y; Qureshi, ZA | 1 |
Jain, N; Tewari, VV | 1 |
Ahuja, T; Chen, D; Chen, XJ; Cutro, SR; Dubrovskaya, Y; Holzman, R; Mehta, SA; Papadopoulos, J; Phillips, MS; Scipione, MR | 1 |
Badawi, C; Elhalwagy, H; Kumar, S; O'Kane, M | 1 |
Bhat Y, R; Lewis, LE; Patra, S; Purakayastha, J; Sivaramaraju, VV | 1 |
Garg, A; Goel, A; Nangia, S; Randhawa, VS; Saili, A; Sharma, S | 1 |
Coleman, K; Girard, AM; Lavallade, L; Levasseur, P; Miossec, C; Pace, J | 1 |
Antonucci, E; Beumier, M; Cristallini, S; de Backer, D; Donadello, K; Jacobs, F; Roberts, JA; Rondelet, B; Scolletta, S; Taccone, FS; Vincent, JL | 1 |
Baek, JY; Sohn, KM | 1 |
Araya, I; Contreras, S; Fasce, G; Hurtado, V; Núñez, E; Opazo, JL; Quiñones, LA; Saez, E | 1 |
Cotton, F; Creteur, J; Gustot, T; Hites, M; Jacobs, F; Lheureux, O; Surin, R; Taccone, FS; Trepo, E; Vincent, JL; Wolff, F | 1 |
Geerlings, SE; Holleman, F; Schneeberger, C | 1 |
El-Ibiary, S; Gorlitsky, B | 1 |
Beardsley, J; Johnson, J; Liu, P; Luther, V; Ohl, C; Williamson, J | 1 |
Nicholaus, P; Pallangyo, P | 1 |
Deis, AS; Simpson, SQ; Whiles, BB | 1 |
Cetinkaya, RA; Coşkun, O; Eyigün, CP; Görenek, L; Ide, T; Kiliç, S; Senses, Z | 1 |
Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC | 1 |
De Backer, D; Delattre, I; Dugernier, T; Jacobs, F; Laterre, PF; Layeux, B; Spapen, H; Taccone, FS; Vincent, JL; Wallemacq, P; Wittebole, X | 1 |
Subaalaxmi, MV | 1 |
Bansal, D; Gautam, V; Marwaha, N; Marwaha, RK; Oberoi, S; Sharma, RR | 1 |
Adam, HJ; DeCorby, M; Hoban, DJ; Karlowsky, JA; Rennie, R; Zhanel, GG | 1 |
Braun, L; Fairchok, M; Flanagan, R; Mahlen, S; Sainato, R | 1 |
Baird, AD; Floyd, MS; Macwilliam, JL; Mistry, R | 1 |
Bond, CM; Bullard, MJ; Djogovic, D; Meurer, DP; Rowe, BH; Villa-Roel, C | 1 |
Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F | 1 |
Chai, LY; Chee, YL; Chng, WJ; Ding, Y; Hsu, LY; Jin, J; Lee, YM; Poon, LM; Tan, LK | 1 |
Bloom, BT; Chong, E; Delmore, P; Forur, L; Gordon, P; Reynolds, J; Shaw, J; Uner, H | 1 |
Hoppe, UC; Kochanek, M; Larbig, R; Lehman, C; Michels, G; Reda, S; Rottländer, D | 1 |
Chua, A; Jimenez, VE; Tortora, G; Younus, F | 1 |
Deng, S; Han, C; Li, X; Liao, Z; Wang, W; Xu, W | 1 |
Dittrich, P; Maier, A; Matzi, V; Nuhsbaumer, S; Pinter, H; Pinter, J; Smolle, J; Smolle-Jüttner, FM; Tomaselli, F; Woltsche, M | 1 |
Hameed, S; Johnson, M; Lipman, M; Tariq, S; Tyrer, M | 1 |
Marinella, MA | 1 |
Flidel-Rimon, O; Friedman, S; Leibovitz, E; Shinwell, ES | 1 |
Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
Harada, AS; Lau, W | 1 |
Agarwal, N; Agarwal, S; Arya, SC; Solanki, BS | 1 |
Apolônio, ACM; Carvalho, MAR; Coutinho, SC; Diniz, CG; Farias, LM; Martins, WA; Nicoli, JR; Santos, KVD | 1 |
Chow, P; Godambe, S; Maulidi, H | 1 |
Celozzi, E; Gadebusch, HH; Pelak, BA; Stapley, EO | 1 |
Cronberg, S; Ekwall, E; Ganrot-Norlin, K; Jonsson, M; Juhlin, I; Kahlmeter, G; Scheja, A; Thorén, A; Thulin, KE; Tunevall, G | 1 |
Coppens, L; Klastersky, J; Menday, AP; Meunier-Carpentier, F | 1 |
Barbour, AG; Mayer, LW; Spratt, BG | 1 |
de Louvois, J; Hurley, R; Mulhall, A | 1 |
Bodey, GP; Estey, EH; Lawson, RD | 1 |
Demos, CH; Green, E | 1 |
Adam, S; Angehrn, P; Then, R | 1 |
Gel'fand, BR; Gel'fand, EB; Lapshina, IIu; Topazova, EN | 1 |
Klimonova, NV; Lobakov, AI; Nasonov, VN; Savitskaia, KI; Savov, AM | 1 |
Frimodt-Møller, N; Ravn, TJ | 1 |
Croft, RJ; Hilas, A; Mehtar, S | 1 |
Bengtsson, E; Strandell, T; Svanbom, M; Tunevall, G | 1 |
Cushing, RD; Lerner, AM; Williams, BB | 1 |
5 review(s) available for penicillanic acid and Blood Poisoning
Article | Year |
---|---|
Antibiotic Dosing in Continuous Renal Replacement Therapy.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Critical Illness; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Renal Replacement Therapy; Sepsis; Tazobactam; Thienamycins | 2017 |
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States | 2014 |
Delftia lacustris septicemia in a pheochromocytoma patient: case report and literature review.
Topics: Adrenal Gland Neoplasms; Aged; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Delftia; DNA, Bacterial; DNA, Ribosomal; Gram-Negative Bacterial Infections; Humans; Male; Penicillanic Acid; Pheochromocytoma; Piperacillin; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, DNA; Tazobactam | 2015 |
Febrile urinary tract infections: pyelonephritis and urosepsis.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Diabetes Complications; Fever; Humans; Immunocompromised Host; Levofloxacin; Penicillanic Acid; Pyelonephritis; Randomized Controlled Trials as Topic; Risk Factors; Sepsis; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2016 |
Review of clinical experience with amdinocillin monotherapy and comparative studies.
Topics: Adolescent; Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Bacterial Infections; Child; Cholecystitis; Clinical Trials as Topic; Diarrhea; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Penicillanic Acid; Sepsis; Typhoid Fever; Urinary Tract Infections | 1983 |
11 trial(s) available for penicillanic acid and Blood Poisoning
Article | Year |
---|---|
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
Topics: Adult; Anti-Bacterial Agents; Drug Monitoring; Female; Humans; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2022 |
Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; India; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Sepsis; Treatment Outcome | 2014 |
Role of prophylactic antibiotics in neonates born through meconium-stained amniotic fluid (MSAF)--a randomized controlled trial.
Topics: Amikacin; Amniotic Fluid; Anti-Bacterial Agents; Antibiotic Prophylaxis; Double-Blind Method; Female; Humans; Infant, Newborn; Infusions, Intravenous; Male; Meconium; Meconium Aspiration Syndrome; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pregnancy; Prospective Studies; Sepsis | 2015 |
[A multicenter clinical trial of piperacillin/tazobactam in burn infection].
Topics: Adult; Burns; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Sepsis; Tazobactam; Treatment Outcome | 2002 |
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
Mecillinam and ampicillin separately or combined in gram-negative septicemia.
Topics: Adult; Aged; Amdinocillin; Ampicillin; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Exanthema; Female; Half-Life; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Sepsis | 1980 |
Carbenicillin plus cefazolin with or without mecillinam as an early treatment of bacteremia caused by gram-negative organisms: randomized double-blind study.
Topics: Amdinocillin; Carbenicillin; Cefazolin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Penicillanic Acid; Random Allocation; Sepsis | 1980 |
Mecillinam (Selexidin) in the treatment of neonates.
Topics: Amdinocillin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Penicillanic Acid; Penicillins; Sepsis | 1981 |
Review of clinical experience with amdinocillin monotherapy and comparative studies.
Topics: Adolescent; Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Bacterial Infections; Child; Cholecystitis; Clinical Trials as Topic; Diarrhea; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Penicillanic Acid; Sepsis; Typhoid Fever; Urinary Tract Infections | 1983 |
[Piperacillin/tazobactam in the treatment of abdominal sepsis in patients with peritonitis].
Topics: Abdominal Abscess; Adult; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 1997 |
[Use of piperacillin-tazobactam in abdominal surgery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Sepsis; Surgical Wound Infection; Tazobactam; Treatment Outcome | 1997 |
58 other study(ies) available for penicillanic acid and Blood Poisoning
Article | Year |
---|---|
The concomitant use of vancomycin and piperacillin-tazobactam is associated with acute kidney injury (AKI) in extremely low birth weight infants (ELBW).
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis.
Topics: Anti-Bacterial Agents; Drug Monitoring; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2022 |
Evaluation of Intravenous Push Piperacillin-Tazobactam on Time to Antibiotic Administration in Emergency Department Patients with Sepsis.
Topics: Anti-Bacterial Agents; Emergency Service, Hospital; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis | 2023 |
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's reply.
Topics: Anti-Bacterial Agents; Drug Monitoring; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2022 |
The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsis.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2022 |
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefoxitin; Humans; Male; Pancreatic Fistula; Pancreaticoduodenectomy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Surgical Wound Infection | 2023 |
Microdialysis as a safe and feasible method to study target-site piperacillin-tazobactam disposition in septic piglets and children.
Topics: Animals; Anti-Bacterial Agents; Child; Humans; Microdialysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Swine; Tazobactam | 2023 |
Bacteraemia and liver abscess due to
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Liver Abscess; Male; Metronidazole; Middle Aged; Nausea; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Treatment Outcome; Vomiting | 2017 |
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin | 2017 |
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?
Topics: Anti-Bacterial Agents; Combined Modality Therapy; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Vancomycin | 2017 |
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cost of Illness; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Retrospective Studies; Sepsis; Taxoids; Tazobactam | 2017 |
Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Bacterial Infections; beta-Lactams; Cefotaxime; Drug Monitoring; Female; Humans; Length of Stay; Male; Meropenem; Patient Readmission; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Sweden; Thienamycins | 2018 |
Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.
Topics: Blood Specimen Collection; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Monitoring; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Tazobactam | 2018 |
Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactamases; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Female; Imipenem; Injections, Intramuscular; Injections, Intraperitoneal; Intraabdominal Infections; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Treatment Outcome | 2013 |
Reply to Soman et al and Frippiat et al.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis | 2013 |
Are prolonged/continuous infusions of β-lactams for all?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis | 2013 |
Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Critical Illness; Extracellular Fluid; Female; Half-Life; Hemofiltration; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Tazobactam | 2014 |
Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.
Topics: Aged; Anti-Bacterial Agents; Cost-Benefit Analysis; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Length of Stay; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Survival Analysis; Syndrome; Tertiary Healthcare | 2014 |
Unusual presentation of PRES in the postnatal period.
Topics: Adult; Anti-Bacterial Agents; Antihypertensive Agents; Critical Care; Diagnosis, Differential; Female; Fluid Therapy; Follow-Up Studies; Headache; Humans; Labetalol; Magnesium Sulfate; Magnetic Resonance Imaging; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Posterior Leukoencephalopathy Syndrome; Postpartum Period; Seizures; Sepsis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Cerebral abscess due to Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Drainage; Frontal Lobe; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Long Term Adverse Effects; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Serratia marcescens; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Efficacy of a Ceftazidime-Avibactam combination in a murine model of Septicemia caused by Enterobacteriaceae species producing ampc or extended-spectrum β-lactamases.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Drug Combinations; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2014 |
β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Sepsis; Serum; Thienamycins; Treatment Outcome | 2015 |
A Non-inferiority Pilot Study Comparing the Clinical Efficacy and Safety of Generic Wide-spectrum Antibiotic Use in Septic Oncology Patients.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drugs, Generic; Female; Humans; Imipenem; Male; Middle Aged; Oncology Service, Hospital; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sepsis; Sulbactam; Treatment Outcome | 2015 |
Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.
Topics: Aged; Anti-Bacterial Agents; Belgium; Case-Control Studies; Chromatography, High Pressure Liquid; Critical Illness; Databases, Factual; Drug Monitoring; Female; Humans; Liver Cirrhosis; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thienamycins | 2016 |
A Common But Not so Typical Elevated Anion Gap.
Topics: Acetone; Acidosis; Adult; Anti-Bacterial Agents; Blood Glucose; Confusion; Diabetes Complications; Fever; Fluid Therapy; Humans; Leg Injuries; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Sodium Bicarbonate; Staphylococcal Infections; Vancomycin | 2016 |
Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Sepsis; Vancomycin | 2016 |
Disseminated tungiasis in a 78-year-old woman from Tanzania: a case report.
Topics: Aged; Animals; Anti-Bacterial Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Ectoparasitic Infestations; Extremities; Female; Ferrous Compounds; Folic Acid; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Poverty Areas; Quality of Life; Sepsis; Severity of Illness Index; Tanzania; Tetanus Toxoid; Tolvaptan; Treatment Outcome; Tunga; Tungiasis; Vitamins | 2016 |
Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Comorbidity; Disease Progression; Female; Hospital Mortality; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Sex Factors; Shock, Septic; Time Factors; Time-to-Treatment; Vasoconstrictor Agents | 2017 |
The effect of methylprednisolone on treatment in rats with induced sepsis.
Topics: Animals; Disease Models, Animal; Methylprednisolone; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Sepsis | 2009 |
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic | 2010 |
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Shock, Septic; Tazobactam; Thienamycins | 2010 |
Septicemic melioidosis.
Topics: Humans; Male; Melioidosis; Penicillanic Acid; Piperacillin; Sepsis; Tazobactam; Time Factors; Treatment Outcome | 2010 |
Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia.
Topics: Acute Lung Injury; Anemia, Aplastic; Animals; Anti-Bacterial Agents; Antilymphocyte Serum; Bacterial Infections; Bone Marrow Transplantation; Child; Cyclophosphamide; Horses; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Transplantation Conditioning; Vancomycin; Vidarabine | 2011 |
Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood; Canada; Candida; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Drug Resistance, Fungal; Emergency Service, Hospital; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Infant, Newborn; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Outpatient Clinics, Hospital; Patients' Rooms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Prevalence; Sepsis | 2011 |
Severe human parechovirus sepsis beyond the neonatal period.
Topics: Anti-Bacterial Agents; Blood Coagulation Disorders; Ceftriaxone; Enterocolitis, Necrotizing; Enzyme Inhibitors; Fever; Heart Failure; Hepatitis; Humans; Infant; Male; Parechovirus; Penicillanic Acid; Picornaviridae Infections; Piperacillin; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sepsis; Sequence Analysis, RNA; Tazobactam | 2011 |
Piperacillin/tazobactam induced thrombocytopaenia--a delayed response.
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Platelet Count; Sepsis; Thrombocytopenia; Time Factors | 2012 |
Pilot study comparing sepsis management with and without electronic clinical practice guidelines in an academic emergency department.
Topics: Aged; Anti-Bacterial Agents; Clinical Protocols; Disease Management; Emergency Service, Hospital; Female; Hospitals, Teaching; Humans; Internet; Male; Middle Aged; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sepsis; Shock, Septic; Treatment Outcome | 2013 |
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult | 2013 |
Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.
Topics: Academic Medical Centers; Adult; Bacteremia; Carbapenems; Ceftazidime; Drug Resistance, Multiple; Febrile Neutropenia; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prevalence; Prospective Studies; Risk Factors; Sepsis; Singapore; Tazobactam; Treatment Outcome; Universities | 2012 |
Results of a two-center, before and after study of piperacillin-tazobactam versus ampicillin and gentamicin as empiric therapy for suspected sepsis at birth in neonates ≤ 1500 g.
Topics: Alkaline Phosphatase; Ampicillin; Apgar Score; Diaper Rash; Female; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Treatment Outcome | 2013 |
[Systemic hantavirus-infection in a comatose HIV patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Coma; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Hemorrhagic Fever with Renal Syndrome; Hepatitis B, Chronic; Humans; Male; Penicillanic Acid; Piperacillin; Puumala virus; Respiratory Distress Syndrome; Sepsis; Tazobactam | 2013 |
Lemierre's disease caused by co-infection of Arcanobacterium haemolyticum and Fusobacterium necrophorum: a case report.
Topics: Actinomycetales; Actinomycetales Infections; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Fusobacterium Infections; Humans; Jugular Veins; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thrombophlebitis; Vancomycin | 2002 |
Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.
Topics: Adult; Aged; Area Under Curve; Enzyme Inhibitors; Female; Humans; Lung; Male; Microdialysis; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Sepsis; Tazobactam | 2003 |
Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Gentamicins; Glucocorticoids; HIV Infections; Humans; Lymphocyte Count; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Disease, Chronic Obstructive; Respiration, Artificial; Sepsis; Skin Diseases; Tazobactam; Treatment Outcome | 2005 |
Group C streptococcal sepsis complicating Fournier gangrene.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Debridement; Diabetes Mellitus, Type 2; Drug Combinations; Fournier Gangrene; Humans; Male; Penicillanic Acid; Perineum; Piperacillin; Scrotum; Sepsis; Streptococcal Infections; Tazobactam | 2005 |
The use of piperacillin/tazobactam (in association with amikacin) in neonatal sepsis: efficacy and safety data.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant, Newborn; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis | 2006 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Use of cefepime for the treatment of infections caused by extended spectrum: beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals, Urban; Humans; India; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thienamycins | 2007 |
Comparative activity of ertapenem and piperacillin tazobactam in a murine systemic infection model with Bacteroides fragilis and Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Blood; Colony Count, Microbial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Mice; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 2007 |
Suspected drug reaction with piperacillin/tazobactam, in a premature infant.
Topics: Anti-Bacterial Agents; Exanthema; Humans; Infant, Newborn; Infant, Premature; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Tazobactam | 2008 |
Quaternary heterocyclylamino beta-lactams. IV. Comparison of the in vivo antibacterial activities of L-640,876, mecillinam, cefoxitin and cefotaxime.
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Cephalosporins; Gram-Negative Bacteria; Kinetics; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Sepsis; Tissue Distribution | 1983 |
Mecillinam resistance in Escherichia coli: dissociation of growth inhibition and morphologic change.
Topics: Adult; Amdinocillin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Humans; Male; Mutation; Penicillanic Acid; Penicillin Resistance; Phenotype; Sepsis | 1981 |
Amdinocillin: use alone or in combination with cefoxitin or carbenicillin-ticarcillin.
Topics: Acute Disease; Adolescent; Adult; Aged; Amdinocillin; Bacterial Infections; Carbenicillin; Cefoxitin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Neutrophils; Penicillanic Acid; Penicillins; Sepsis; Ticarcillin | 1983 |
(6R)-6-(substituted methyl)penicillanic acid sulfones: new potent beta-lactamase inhibitors.
Topics: Animals; beta-Lactamase Inhibitors; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Sepsis; Structure-Activity Relationship; Sulfones | 1993 |
Mecillinam in urinary tract infections and in septicaemia.
Topics: Adult; Aged; Amdinocillin; Anti-Bacterial Agents; Drug Evaluation; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Penicillin Resistance; Sepsis; Urinary Tract Infections | 1979 |
A non-comparative study of parenteral ampicillin and sulbactam in intra-thoracic and intra-abdominal infections.
Topics: Abdomen; Adult; Aged; Ampicillin; Bacteria; Bacterial Infections; beta-Lactamases; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillin Resistance; Respiratory Tract Infections; Sepsis; Sulbactam; Time Factors | 1986 |
Azidocillin treatment of enterococcal septicemia.
Topics: Acetamides; Aged; Ampicillin; Azides; Cholecystectomy; Drug Synergism; Erythromycin; Humans; Male; Middle Aged; Penicillanic Acid; Penicillin G; Penicillins; Postoperative Complications; Sepsis; Streptococcal Infections; Streptomycin; Urinary Catheterization | 1972 |
Letter: Severe combined nephrotoxicity of BL-P1654 and gentamicin.
Topics: Adult; Blood Bactericidal Activity; Carbenicillin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Humans; Kidney Diseases; Penicillanic Acid; Polymyxins; Pseudomonas aeruginosa; Sepsis | 1974 |